Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 4

3(33.3%)

9Total

N/A(6)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT06964074Not ApplicableActive Not Recruiting

PEP and O-PEP Device for Nebulization in Cystic Fibrosis

Role: lead

NCT05752708Recruiting

Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery

Role: lead

NCT03788057Not ApplicableCompleted

Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma

Role: lead

NCT05801952Not ApplicableUnknown

PEP and OPEP Devices in Cystic Fibrosis

Role: lead

NCT04036721Phase 4Suspended

Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

Role: lead

NCT04916834Unknown

Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

Role: lead

NCT03393702Phase 4Completed

Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin

Role: lead

NCT04509921Not ApplicableCompleted

Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test

Role: lead

NCT03444636Phase 4Completed

Multimodal Analgesia in Children and Adolescents After the Ravitch Procedure and Thoracotomy

Role: lead

NCT03894475Not ApplicableCompleted

Non-inferiority of Portable Versus Desktop Spirometry

Role: lead

NCT03488459Not ApplicableCompleted

Influence of Preoperative Support on Anxiety, Pain and Satisfaction With Postoperative Analgesia

Role: lead

All 11 trials loaded